Erasmus MC / location Sophia Kinderziekenhuis

Rotterdam 3015 GJ

0 studies enrolling now · 2 studies all time

What they study most

Angelman Syndrome, Solid Tumor

Studies at this site

• A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS) — Completed
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors — Stopped early